In FY23, IDEXX VetLab consumables business grew by 12.7% organically in revenue and veterinary software and recurring part of diagnostic imaging grew by 18.8% year-over-year. The growth from ...

This division plays a significant role in generating recurring revenue, largely due to products like IDEXX VetLab consumables and SNAP rapid assay test kits. These products are integral to the ...

Further, the company generates substantial revenues and margins from selling consumables used in IDEXX VetLab instruments. In the fourth quarter of 2023, IDEXX's CAG Diagnostics recurring revenues ...

CAG Diagnostics recurring revenue growth of 3% as reported and 4.5% organic was supported by double-digit IDEXX VetLab consumables organic revenue growth and benefits from IDEXX execution drivers ...

The combined assessment of analysts suggests that 'Revenue- CAG Diagnostics recurring revenue- IDEXX VetLab consumables' will likely reach $333.87 million. The estimate suggests a change of +5.4% ...

IDEXX VetLab consumables revenues are likely to have increased in the United States and international regions. Similar to the last quarter, gains are expected to have been supported by year-over ...

continued growth in our premium IDEXX VetLab instrument installed base, and nearly 700 pre-orders of IDEXX inVue Dx Cellular Analyzer, which will begin shipping later in the fourth quarter ...

After running a test using Idexx's equipment, a vet can analyze it in-house using the VetLab Station and make a diagnosis. Each test uses consumable products like slides, test cartridges ...